organic heterocyclic compound tofacitinib 0 312.16986 312.377 pubmed:22916341 C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2nccc12 pubmed:21952978 patent:WO2007107318 pubmed:23150971 pubmed:22147632 pubmed:23150970 pdb-ccd:MI1 InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1 CP-690550 pubmed:22474037 reaxys:11647225 pubmed:22924949 pubmed:22802024 pubmed:22525048 CHEBI:71200 CP 690550 wikipedia.en:Tofacitinib A pyrrolopyrimidine that is pyrrolo[2,3-<em>d</em>]pyrimidine substituted at position 4 by an <em>N</em>-methyl,<em>N</em>-(1-cyanoacetyl-4-methylpiperidin-3-yl)amino moiety. Used as its citrate salt to treat moderately to severely active rheumatoid arthritis. patent:WO2010123919 tofacitinibum pubmed:22233204 pubmed:21971513 pubmed:22607938 kegg.drug:D09970 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile tofacitinib pubmed:22607178 pubmed:22894574 pubmed:22357358 pubmed:22006202 pubmed:22873530 pubmed:22960764 pubmed:22576568 pubmed:22873531 chebi_ontology 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile Tasocitinib UJLAWZDWDVHWOW-YPMHNXCESA-N pubmed:22460142 pubmed:22682022 pubmed:22899318 pubmed:23055694 pubmed:22591402 cas:477600-75-2 patent:WO2007012953 C16H20N6O pubmed:23150969 drugcentral:4713 lincs.smallmolecule:LSM-1227